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levels in foods aren’t required to be on labels and are rarely provided.
Phosphorus-containing food additives are widely used in all types of foods,
often where they have never been seen before. It is common practice to relate
phosphorus content in food closely to protein value. This can only be reliable
for unprocessed raw materials. Any processed foods may have phosphorus
additives which will not be evident on the labels and protein is measured by
Kjeldahl nitrogen, which falsely assumes all nitrogen in foods is protein-related.
The reality and future directions of the food industry need to be taken into
account when making nutritional recommendations. The way forward is to
understand the challenges the food industry faces and work with them to
elucidate the problems and seek solutions.
http://dx.doi.org/10.1016/j.krcp.2012.04.594
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In a major Victorian hospital, dietitians observed that requests tomedical staff
to prescribe nutritional supplements via themedication chart were inefﬁcient.
This led to delays in the deliveryof nutritional recommendations, thus
compromising patients’nutritional status. Lean Methodology was applied to
simplify theordering of patients’ nutritional supplements as medication(NSAM)
by dietitians. A literature review was conducted. Directobservation and value
stream mapping were used to identifyprocess time and wasted time related to
NSAM prescription. Adetailed root cause analysis of identiﬁed issues was
undertaken,followed by the development of an implementation plan.
Thefollowing problems were identiﬁed: ordering process wascomplicated and
not linear, delay in patient receiving NSAM (2.8days, range 0–23 days), and 60%
repeat requests by the dietitian forNSAM. An implementation plan was
developed which included:submission to the Medical Executive Committee to
seekprescribing privileges for dietitians; dietetic competency trainingand
credentialing, communication strategy, development ofprescribing and
administering procedures; and ward education.Dietetic prescribing privileges
were granted, implemented, andevaluation of this change in dietetic practice
undertaken. Inconclusion, application of Lean Methodology enabled dietitians
toclearly examine, in a systematic manner, delays, risks andinefﬁciencies with
our current process of ordering NSAM. It led toa plan of action to improve
quality of care to our patients, includingrenal patients, and reduce waste in our
health care setting by timelyand appropriate commencement of NSAM.
http://dx.doi.org/10.1016/j.krcp.2012.04.595
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The understanding of intestinal function in chronic kidney disease (CKD)
has been important elements in the clinical management of CKD with
dietary and drug therapy.
Numerous studies have indicated that CKD patients or model rats have
enzymatic abnormalities and impairments of absorptive function in the
small intestine. However, it
has been still unclear how different of the intestinal function in CKD. In this
study, we demonstrated the microarray analysis of global gene expression in
intestine of adenine-induced CKD rat. DNA microarray analysis using
Affymextrix rat gene chip revealed that CKD caused great changes in gene
expression in the rat duodenum: about 400 genes exhibited more than a two-
fold change in expression level. Gene ontology analysis showed that a global
regulation of genes by CKD involved in iron ion binding, alcoholic, organic acid
and lipid metabolism. Furthermore, we foundmarkedly changes of a number of
intestinal transporters gene expression related to iron metabolism. These
results suggest that CKD may alter some nutrient metabolism in the small
intestine by modifying the expression of speciﬁc genes. The intestinal
transcriptome database of CKD might be useful to develop the novel drugs or
functional foods for CKD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.596
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The paradoxical risk of BMI on mortality is known in CKD as well in dialysis
populations, but studies of CVD risk in CKD including underweight is limited.
We hypothesized lean CKD increase the CVD risk, contributing different factors
from obese. 2,676 CKD patients recruited from 11 outpatients’ hospitals. BMI
and estimated GFR (eGFR) were calculated, and change of eGFR and CVD
mortality during 2 years were collected. Patients were divided by BMI under
cut off value of normal, thus 7% grouped in lean subjects (BMI o18.5). Systolic
blood pressure (sBP), albumin, hemoglobin, age and prevalence of diabetes
were lower in lean BMI group compared to other subjects. However CVD
history, urinary protein, baseline eGFR and smoking didn’t differ between the
groups. The lean BMI increased signiﬁcantly the risk of CVD mortality, in spite
of low prevalence of comorbidities and young age in unadjusted model (HR
2.38, 95%CI 1.49-5.21, po0.01). This signiﬁcance remained after adjusted for
CVD risk factors, such as primary disease of CKD, age, sex, smoking, albumin,
cholesterol, sBP and eGFR. On the other hand, BMI was not associated with the
decline rate of eGFR.We concluded that BMI less than 18.5 was an independent
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This study aimed to analyze the survival and the risk factors associated
with mortality in diabetic CAPD patients in Southern China. This single-
center prospective cohort study enrolled all incident CAPD patients from
Jan 2006 to Dec 2009 and followed-up until Dec 2011.Survival in diabetic
and non-diabetic CAPD patients and the risk factors on mortality in the
diabetic CAPD subjects were evaluated. Among 841 incident CAPD subjects
in this study, 193 patients (22.9%) were diabetes. The mean vintage of
CAPD was 29.4715.5 months. Shorter patient survival time was found in
diabetic patients compared to that of non-diabetic ones (po0.01). The 1-,
3- and 5-year patient survival rates were 90%, 64% and 40% in diabetes and
95%, 88% and 75% in non-diabetes, respectively (po0.01). There was no
signiﬁcant difference in the death-censored technique survival time
between diabetic and non-diabetic patients. The 1-, 3- and 5-year
technique survival rates were 96%, 88% and 86% in diabetic, while 99%, 93%
and 87% in non-diabetic patients, respectively. Diabetic CAPD patients that
died during the follow-up period had older age(63.4710.5 vs.58.6710.4
yrs, po0.01), higher proportion of cardiovascular diseases (CVD)(64.9% vs.
47.1%, po0.05), higher level of hsCRP [5.1(1.511.7) vs. 1.8 (0.87.2)]
mg/L, po0.01), but lower levels of haemoglobin (95.5720.2 vs.
103.4719.2g/L, po0.01), serum albumin (33.774.0 vs.35.374.9g/L,
po0.05) and 24h urine output [600(300813) vs. 800(5001100]ml/d,
po0.01) compared to the survivors. The presence of CVD, advanced age,
higher glycosylated haemoglobin, lower hemoglobin and serum albumin at
the initiation of PD were independent predictors of death in diabetic
patients.It was concluded that survival of diabetic CAPD patients is not as
good as that of non-diabetic patients in Southern Chinese patients, but
better than those reported by other previous studies. Better management
of modiﬁable risk factors such as hyperglycaemia, anemia and
hypoalbuminemia may improve outcomes of diabetic PD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.598
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